Reuters - IMS Health Inc (RX.N), which tracks market data on the pharmaceutical industry, said second-quarter profit dropped 19 percent and warned full-year results would probably miss its projections as customers cut spending. The company also announced a restructuring to bring down costs, including shedding 850 positions, or 11 percent of the global workforce.
